Regencell Bioscience Holdings Limited - Ordinary Shares (RGC)

Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular session. The company's market cap stands at $6.3 million. Regencell Bioscience (NASDAQ:RGC) stock moved upwards by

Regencell Bioscience doesn't have a product yet, and there's no indication that one is on the way.

Regencell Bioscience is working on TCM opportunities, but what exactly is TCM?

Don't follow general market sentiment when it comes to these two stocks.

As the final bells rang on the 2025 trading year, investors in Regencell Bioscience (NASDAQ: RGC) were met with a sobering reality check. The Hong Kong-based biotech firm, which has enjoyed a meteoric and often volatile rise over the past twelve months, saw its stock slide 8.3% on December

Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Is the stock likely to keep surging? The answer seems pretty clear.

Here's a look at the most-watched earnings reports for this week including Nvidia, PDD, Walmart, Palo Alto and more.

Beyond Meat is a textbook example of why primary data sources, such as company filings with the Securities and Exchange Commission, are so important.

AI can pick stocks, but that doesn't mean it will do a good job. Here's a look at how the choices made by 7 leading AIs performed over a 90-day time period.